Share on LinkedInShare on LinkedIn

ARTICLE · 10 FEBRUARY 2026

Inside HPE Europe 2025 | Accelerating Value Creation: Mastering Performance Optimization For Exit Success

HPE Europe convened more than 300 top-tier investors, executive management teams, investment bankers, and lenders.

United StatesFood, Drugs, Healthcare, Life Sciences

HPE Europe convened more than 300 top-tier investors, executive management teams, investment bankers, and lenders. Our in-depth panels explored the future of the industry and the critical trends shaping deal activity for the year ahead.

⁠During our session on "Accelerating value creation" we discussed how, in a market that's finally warming up, value creation that actually prices is grounded in facts, not fanfare. Healthcare sellers who show a defendable "new normal," tie KPIs to cash, and pick the right exit track, from GP-leds to well-timed trade sales, are getting deals done. The playbook now is disciplined underwriting, credible internationalisation (often US traction), and evidence over anecdotes.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from